Given that the mbIL-15 induces a reduced effector population and a higher proportion of naïve T cells within ADP-520 (Figure 2F), we next evaluated the potency of ADP-520 against CD70-expressing RCC cell lines, 786-O and ACHN. The gene discussed is CD70; the disease is renal cell carcinoma.